MTNB
AMEX · Biotechnology
Matinas Biopharma Holdings I
$0.23
-0.01 (-2.92%)
Open$0.24
Previous Close$0.24
Day High$0.24
Day Low$0.23
52W High$3.09
52W Low$0.23
Volume—
Avg Volume29.37M
Market Cap3.54M
P/E Ratio—
EPS$-1.62
SectorBiotechnology
Analyst Ratings
Strong Sell
7 analysts
Price Target
+16,779.8% upside
Current
$0.23
$0.23
Target
$39.33
$39.33
$22.47
$39.33 avg
$48.65
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 545.4K | 506.2K | 440.2K |
| Net Income | -151,735 | -126,413 | -142,621 |
| Profit Margin | -27.8% | -25.0% | -32.4% |
| EBITDA | -193,711 | -167,268 | -163,365 |
| Free Cash Flow | -191,504 | -185,587 | -103,932 |
| Rev Growth | -0.1% | +13.2% | +21.4% |
| Debt/Equity | 0.35 | 0.35 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $250.82 | +0.83% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $417.84 | +0.40% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.14 | +1.67% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $516.44 | -1.77% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $805.97 | +1.00% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.12 | +1.42% | 35.2 | 28.41B |